MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$654K
Tax credit
receivable
$1,721K
Cash and cash
equivalents
$7,528K
Deposits and other assets
$82K
In-process research and
development
$19,614K
Right of use asset
$942K
Restricted cash
$46K
Property and equipment,
net
$249K
Total current assets
$9,903K
Total assets
$30,836K
Total liabilities and
stockholders' equity
$30,836K
Total stockholders'
equity
$6,738K
Total liabilities
$24,098K
Accumulated deficit
-$356,714K
Treasury stock at cost,
28,809 shares at...
$288K
Accumulated other
comprehensive income (loss)
$763K
Additional paid-in capital
$362,968K
Non-current operating lease
liability
$433K
Non-current deferred
research and development...
$215K
Loan payable -
non-current
$1,654K
Non-current contingent
consideration
$10,793K
Total current
liabilities
$11,003K
Common stock, 0.001 par
value 350,000,000...
$9K
Operating lease
liability-current portion
$618K
Loans
payable-current
$57K
Deferred research and
development tax...
$1,101K
Accrued employee
benefits
$747K
Accrued expenses
$7,685K
Accounts payable
$795K
Back
Back
Balance Sheet
source: myfinsight.com
Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX)